Integrin-αV-mediated activation of TGF-β regulates anti-tumour CD8 T cell immunity and response to PD-1 blockade
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Integrin-αV-mediated activation of TGF-β regulates anti-tumour CD8 T cell immunity and response to PD-1 blockade
Authors
Keywords
-
Journal
Nature Communications
Volume 12, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-09-01
DOI
10.1038/s41467-021-25322-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cryo-EM Reveals Integrin-Mediated TGF-β Activation without Release from Latent TGF-β
- (2020) Melody G. Campbell et al. CELL
- Selective inhibition of TGFβ1 activation overcomes primary resistance to checkpoint blockade therapy by altering tumor immune landscape
- (2020) Constance J. Martin et al. Science Translational Medicine
- Clonal Deletion of Tumor-Specific T Cells by Interferon-γ Confers Therapeutic Resistance to Combination Immune Checkpoint Blockade
- (2019) Chien-Chun Steven Pai et al. IMMUNITY
- Integrin as a Molecular Target for Anti-cancer Approaches in Lung Cancer
- (2019) NITHIKOON AKSORN et al. ANTICANCER RESEARCH
- Single-cell transcriptomic analysis of tissue-resident memory T cells in human lung cancer
- (2019) James Clarke et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Integrin subunit alpha V promotes growth, migration, and invasion of gastric cancer cells
- (2019) Huashe Wang et al. PATHOLOGY RESEARCH AND PRACTICE
- Regulation of antitumour CD8 T-cell immunity and checkpoint blockade immunotherapy by Neuropilin-1
- (2019) Marine Leclerc et al. Nature Communications
- Are Integrins Still Practicable Targets for Anti-Cancer Therapy?
- (2019) Alday-Parejo et al. Cancers
- iRGD: A Promising Peptide for Cancer Imaging and a Potential Therapeutic Agent for Various Cancers
- (2019) Houdong Zuo Journal of Oncology
- αvβ3-integrin regulates PD-L1 expression and is involved in cancer immune evasion
- (2019) Andrea Vannini et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Integrin-Mediated TGFβ Activation Modulates the Tumour Microenvironment
- (2019) Brown et al. Cancers
- MMP14 in Sarcoma: A Regulator of Tumor Microenvironment Communication in Connective Tissues
- (2019) Jordi Gonzalez-Molina et al. Cells
- Migratory DCs activate TGF-β to precondition naïve CD8+ T cells for tissue-resident memory fate
- (2019) Vinidhra Mani et al. SCIENCE
- CD103+Tumor-Resident CD8+T Cells Are Associated with Improved Survival in Immunotherapy-Naïve Melanoma Patients and Expand Significantly During Anti–PD-1 Treatment
- (2018) Jarem Edwards et al. CLINICAL CANCER RESEARCH
- TGFβ drives immune evasion in genetically reconstituted colon cancer metastasis
- (2018) Daniele V. F. Tauriello et al. NATURE
- Tissue-resident memory T cells at the center of immunity to solid tumors
- (2018) Derk Amsen et al. NATURE IMMUNOLOGY
- Enhanced preclinical antitumor activity of M7824, a bifunctional fusion protein simultaneously targeting PD-L1 and TGF-β
- (2018) Yan Lan et al. Science Translational Medicine
- Co-expression of CD39 and CD103 identifies tumor-reactive CD8 T cells in human solid tumors
- (2018) Thomas Duhen et al. Nature Communications
- Bifunctional immune checkpoint-targeted antibody-ligand traps that simultaneously disable TGFβ enhance the efficacy of cancer immunotherapy
- (2018) Rajani Ravi et al. Nature Communications
- TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
- (2018) Sanjeev Mariathasan et al. NATURE
- Identification of essential genes for cancer immunotherapy
- (2017) Shashank J. Patel et al. NATURE
- Force interacts with macromolecular structure in activation of TGF-β
- (2017) Xianchi Dong et al. NATURE
- Blocking immunosuppression by human Tregs in vivo with antibodies targeting integrin αVβ8
- (2017) Julie Stockis et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Acquired IFNγ resistance impairs anti-tumor immunity and gives rise to T-cell-resistant melanoma lesions
- (2017) Antje Sucker et al. Nature Communications
- Induction of resident memory T cells enhances the efficacy of cancer vaccine
- (2017) Mevyn Nizard et al. Nature Communications
- TGFβ Signaling Intersects with CD103 Integrin Signaling to Promote T-Lymphocyte Accumulation and Antitumor Activity in the Lung Tumor Microenvironment
- (2016) Marie Boutet et al. CANCER RESEARCH
- Loss of IFN-γ Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4 Therapy
- (2016) Jianjun Gao et al. CELL
- Isolation of T-Cell Receptors Specifically Reactive with Mutated Tumor-Associated Antigens from Tumor-Infiltrating Lymphocytes Based on CD137 Expression
- (2016) Maria Parkhurst et al. CLINICAL CANCER RESEARCH
- Stromal cells control the epithelial residence of DCs and memory T cells by regulated activation of TGF-β
- (2016) Javed Mohammed et al. NATURE IMMUNOLOGY
- Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma
- (2016) Jesse M. Zaretsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade
- (2016) N. McGranahan et al. SCIENCE
- Primary Resistance to PD-1 Blockade Mediated by JAK1/2 Mutations
- (2016) Daniel Sanghoon Shin et al. Cancer Discovery
- Novel TGF-β inhibitors ready for prime time in onco-immunology
- (2016) Armand de Gramont et al. OncoImmunology
- Integrin αvβ8-Mediated TGF-β Activation by Effector Regulatory T Cells Is Essential for Suppression of T-Cell-Mediated Inflammation
- (2015) John J. Worthington et al. IMMUNITY
- T-box Transcription Factors Combine with the Cytokines TGF-β and IL-15 to Control Tissue-Resident Memory T Cell Fate
- (2015) Laura K. Mackay et al. IMMUNITY
- CD8+CD103+Tumor–Infiltrating Lymphocytes Are Tumor-Specific Tissue-Resident Memory T Cells and a Prognostic Factor for Survival in Lung Cancer Patients
- (2015) Fayçal Djenidi et al. JOURNAL OF IMMUNOLOGY
- Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer
- (2015) Hossein Borghaei et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inhibition of the αvβ6 integrin leads to limited alteration of TGF-α-induced pulmonary fibrosis
- (2014) Satish K. Madala et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- PD-1 identifies the patient-specific CD8+ tumor-reactive repertoire infiltrating human tumors
- (2014) Alena Gros et al. JOURNAL OF CLINICAL INVESTIGATION
- Smad and NFAT Pathways Cooperate To Induce CD103 Expression in Human CD8 T Lymphocytes
- (2014) M. Mokrani et al. JOURNAL OF IMMUNOLOGY
- PD-1 blockade induces responses by inhibiting adaptive immune resistance
- (2014) Paul C. Tumeh et al. NATURE
- Targeting of Alpha-V Integrins Reduces Malignancy of Bladder Carcinoma
- (2014) Geertje van der Horst et al. PLoS One
- Transforming Growth Factor-β Signaling Controls the Formation and Maintenance of Gut-Resident Memory T Cells by Regulating Migration and Retention
- (2013) Nu Zhang et al. IMMUNITY
- Online Survival Analysis Software to Assess the Prognostic Value of Biomarkers Using Transcriptomic Data in Non-Small-Cell Lung Cancer
- (2013) Balázs Győrffy et al. PLoS One
- Mucosal Imprinting of Vaccine-Induced CD8+ T Cells Is Crucial to Inhibit the Growth of Mucosal Tumors
- (2013) F. Sandoval et al. Science Translational Medicine
- Preferential Expression of Integrin αvβ8 Promotes Generation of Regulatory T Cells by Mouse CD103+ Dendritic Cells
- (2011) Helena Païdassi et al. GASTROENTEROLOGY
- CD103 is a hallmark of tumor-infiltrating regulatory T cells
- (2011) David Anz et al. INTERNATIONAL JOURNAL OF CANCER
- Intratumoral Induction of CD103 Triggers Tumor-Specific CTL Function and CCR5-Dependent T-Cell Retention
- (2009) K. Franciszkiewicz et al. CANCER RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started